1-1 of 1
Keywords: Renal cell carcinoma
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Subject Area:
Further Areas
Urol Int (2013) 91 (4): 482–483.
Published Online: 16 August 2013
...Masaomi Ikeda; Tetsuo Fujita; Yasuyuki Amoh; Sumiyuki Mii; Kazumasa Matsumoto; Masatsugu Iwamura Sorafenib is an orally administered active multikinase inhibitor for metastatic renal cell carcinoma that is now considered a standard agent. Skin toxicity, such as hand-foot skin reaction, is one...